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S_q Detection of loss of heterozygosity (LOH) and DNA flow cytometry (FCM) we used to trace the
origin of bilateral ovarian cancer from 16 patients. From each tumour the DNA index (DI) and LOH patterns
for chromosomes 1, 3, 6, 11, 17, 18, 22 and X were determined with 36 microsatellite markers. Formalin-fixed,
parffin-embedded as well as frozen specis we used. Flow cytometric cell sorting was used to enrich
tumour cells for polymrase chain reaction (PCR)-driven LOH analysis. Analysis of the LOH data showed
that in 12 of the 16 cases concordance was observed for all informative markers, namely retention of
beterozygosity (ROH) or loss of identical alleles both tumour samples. In four cases discordant LOH
patterns were observed. In two cases the discordant LOH was found for one of the chromosomes tested while
other LOH pattems cearly indicated a unifocal origin. This suggests limited clonal divergence. In the other
two cases all LOH pattems were discordant, most ikely indicating an independent origin. The number of
chromosomes showing LOH ranged from 0 to 6. Comparison of DNA FCM and the LOH data showed that
the latter technique has a higher sensitivity for the detection of a unifocal origin. In 14/16 cas evidence was
found for a unifocal origin, while in two cases clonal divergence was found at LOH kvel and in two other
cases clonal divergence at DNA ploidy klv. In 12 cases the complete observed alelotype had developed
before the formation of metastases, including the two cases showing a large DNA ploidy difference.
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Epithelial cancer of the ovary has the poorest prognosis of all
gynaecological cancers with a 5 year survival of 39% (Boring
et al., 1991). More than 50% of these malignant ovarian
tumours are bilateral (Novak and Woodruff, 1974) and fre-
quently tumour locations are found in other sides of the
gynaecological tract as well. It is often uncertain whether
they represent metastatic disease or multiple primary
tumours, since histopathological characteristics are often not
sufficient to solve this dilemma.
Pejovic et al. (1991) studied this problem by comparative
karyotype analysis and found identical chromosome changes
in 15 ofthe 18 cases for which multiple tumour deposits were
studied, although large karyotypic differences betwen the
cases were observed. In three cases no karyotypic abnor-
malities were observed. Smit et al. (1990) used DNA FCM to
compare DNA indices (DIs) of multiple tumours. In 60% of
the cases the similarity in DI provided evidence for metas-
tatic disease. In addition moleular genetic studies provided
evidence against a multifocal origin. Mok et al. (1992) com-
pared multiple tumours of the same patient for their p53
mutation pattern. In the nine cases investigated the muta-
tions were identical in both tumour sites. Jacobs et al. (1992)
compared tumours on the basis of LOH at different
chromosomes, p53 expression, p53 mutations and X
chromosome inactavation pattern. Statistical analysis showed
that the probability of an independent occurrence of the
tumours was less than 1.5% in 15 of 17 cases.
In the present study we have investigated the clonality of
bilateral ovarian carcinomas by DNA FCM and molecular
genetic analysis with particular attention to possible clonal
divergence after metastasis. To this end we used 36 polymor-
phic microsatellite markers mapping to eight different
chromosomes for LOH analysis. Furthermore, we compared
the discriminating power of DNA FCM as a rapid technique
with the more laborious approach of LOH analysis. To
eliminate the interfering effect of contaminating normal
DNA, we applied flow cytometric cell sortng on the basis of
DNA content to enrich tumour cell populations for PCR-
driven LOH analysis.
Materiaa methods
Specimens
Sixteen cases of epithelial ovarian cancer with bilateral
tumour locations were used (Table I). Nine were formalin-
fixed, paraffin-embedded archival specimens and seven were
snap-frozen fresh specmens stored at - 70C. Tumour cell
percentages were determined by visual examination of
haematoxylin- and eosin-stained sections. When specimens
contained less than 80% tumour cells, they were enriched by
flow cytometric cell sorting (Table I) based on DNA ploidy
as described below. Constitutional DNA was extracted from
peripheral blood leucocytes. If blood was unavailable,
archival paraffin blocks with normal (non-tumour) tissue
from the same patient or flow cytometrically sorted, DNA
diploid, stromal cells from the aneuploid tumour served as
the source for constitutional DNA (Table I).
Flow cytometry and cell sorting
Suspensions of paraffin-embedded nuclei were obtained
according to Hedley et al. (1983) with minor modifications
(Schueler et al., 1993) and stained with propidium iodide
after RNAse treatment. Fresh frozen specimens were pro-
cessed according to the detergent-trypsin method of
Vindelov et al. (1983a). Trout erythrocytes were used as
reference (Vindelov et al., 1983b). Samples were analysed on
a FACScan flow cytometer (Becton Dikinson, Mountain
View, CA, USA). Flow cytometric sorting was performed on
the basis of DNA content on a FACStar flow cytometer
(Becton Dickinson). DIs were calculated according to
accepted criteria (Hiddemann et al., 1984).
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Table I Histology, specimen type and percentages oftumour ells
Histology
Clear cell
Endometrioid
Serous
Undifferentiated
Serous
Endometrioid
Serous
Endometrioid
Serous
Undifferentiated
Serous
Undifferentiated
Undifferentiated
Serous
Serous
Serous
Specime
type
Paraffin
Paraffin
Paraffin
Paraffin
Paraffin
Paraffin
Paraffi
Paraffin
Paraffin
Frozen
Frozn
Frozen
Frozen
Frozen
Frozen
Frozen
Twnor a
Location Percentage
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Left ovary
Right ovary
Left ovary
Left ovary
'Sorted on the basis of DNA ploidy before DNA isolation.
50'
80
70
90
30'
80
10l
50'
60'
70
20'
80a
40'
10'
70'
Twnof b
Location Percentage
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Right ovary
Left ovary
Right ovary
Right ovary
50'
70
80
90
30'
90
50'
60'
40'
50'
30'
60a
80
40'
90'
90'
DNA isolation
DNA was extracted from peripheral blood lymphocytes
according to Miller et al. (1988). DNA from fresh tumour
specmens was isolated as described by Devilee et al. (1989).
DNA from paraffin-embedded tissue was isolated by over-
night incubation of six 10ILm sections in 100lz PK buffer
[10 mmol 1' Tn's-HCI pH 8.3, 0.5% Tween 20, 1 mmol 1'
EDTA 1% proteinase K (w/v)J (Limpens et al., 1993), at
56'C followed by a 10 min incubation at IOO0C to inactivate
proteinase K. To obtain a proper separation of the liquid
and solid phases, the tubes were centrifuged directly while
samples were hot. The liquid phase was carefully pipetted
through the solid paraffin residue laying on top of the
sample. DNA was isolated from the sorted nucleus fractions
as described before (Abeln et al., 1994). Briefly, nuclear
concentrations were adjusted to 50 nuclei per #1 with PK
buffer and incubated overnight at 56'C followed by a 10 min
proteinase K inactivation at lOOC.
Detection ofLOH
The microsatellite markers that were selected on the basis of
heterozygosity and chromosomal location are presented in
Table II. At least one marker was used for each
chromosome, depending on interpretability and infor-
mativeness of the alleles. In non-informative cases, adjacent
markers were used. Analysis of LOH was performed by PCR
on microsatellite markers as described by Weber and May
(1989). Briefly, 2 1 of DNA solution was loaded on a mic-
rotitre plate. Reaction mix was added to a total reaction
volume of 15 g1 containing 3 pmol of the forward and 3 pmol
of the reverse primer, 1% bovine serum albumin (BSA),
0.01% gelatin, 0.1% Triton X-100, lOmmoll-' Tris-HCI
pH9.0, 50mmoll-' potassium chloride, 1.Smmoll-' mag-
nesium chloride, 200 gmol l- dATP, 200 gimol l- dGTP,
200 amol-Il dTTP, 0.25zmol1l' dCTP and 0.1 1l [4-
"PJdCUlP (300O Ci mmol-', 10 gCi l-') (Amersham Neder-
land, 's-Hertogenbosch, The Netherlands) and 0.06U of
Super Taq DNA polymerase (Sphaero Q, HT Biotechnology,
Cambridge, UK). Samples were covered with a drop of
mineral oil (Sigma, St Louis, MO, USA) and were passed
through a temperature cycling programme consisting of
4min at 94'C, 33 cycles of I min at 94"C, 2min at 55"C,
I min at 72"C followed by an additional extension step of
6 min at 72"C in a thermocycling machine (MJ Resarch,
Watertown, MA, USA). Samples were denatured by addition
of a drop of 0.3% xylene cyanoL 0.3% bromophenol blue,
10 mmol 1' EDTA pH 0.90% (v/v) formamide and subjected
to electrophoresis on a 0.4-mm-thick 6.5% polyacrylamide
gel containing 7 mol 1' urea. Gels were dried and exposed to
X-ray fihns (Konica, Tokyo, Japan) for periods ranging from
12 to % h. Results were interpreted by visual comparison of
the allele intensities.
Table H Microsatellite markers
Marker
DIS162
DIS175
APOA2
DIS158
DlS103
D3S1270
D3SI I
GLUT2
D3S1232
IGF2R
F13AI
D6S89
D6S251
D6S249
DI IS554
DI 1S875
DI 1S871
TP53
D17S515
D17S520
D17S513
D17S579
D17S250b
D17S588
46E6
HOX2B
D18S40
D18S35
D18S34
MBP
D22S156
IL-2RB
CYP2D
KALLMAN
DXS453
DXS454
Chromosomal
location
Ip32
Ip2l -qI2
Iq21 -q23
Iq32-q41
1q32-qter
3p
3p21 -pl4
3q26-q26.3
3q21
6q25-q27
6p25-p24
6p24-p23
6ql3-q21.1
6ql3-q21.l
llpl2-pl 1.2
1lpter-pl 1.2
1lpter-pl1.2
17pI3.1
17q22-ter
17pl2
17pl3
17ql2-q21
17ql1.2-q12
17q22-23
17q23-24
17q21.1 -q21.3
18pl 1.21 -ter
18ql1-qI2
18ql1
18q22-qter
22q1I
22ql1.2-qI2
22q13
Xp22.3
Xp11.23-q21.1
Xq21.1-q23
Heterozygosity
0.91
0.80
0.74
0.89
0.88
0.75
0.93
0.91
0.75
0.42
0.78
0.92
0.78
0.46
0.91
0.90
0.77
0.68
0.88
0.77
0.89
0.87
0.94
0.68
0.76
0.74
0.82
0.72
0.81
0.80
0.78
0.91
0.80
0.61
0.72
0.75
Statistics
The difference (d) between the multiple DIs can be caused by
a measurement error or by a true biological difference:
Previously Smit et al. (1990) derived a likelihood ratio (LR)
that determines the probability that d is caused by matched
pairing vs random pairing:
LR=
- e-'4[-.
-1
L e
Where a, is the measurement error variance of the natural
logarithm of the DI (LDI). The calulated value for a, was
0.041, based on repeated flow cytometric experiments (Kute
et al., 1988). ais the variance ofLDI of randomlypaired Dls
of ovarian tumours and was determined to be 0.24 (Smit et
al., 1990).
Case
OVI
OV2
OV3
OV4
OV5
OV6
OV7
OV8
OV9
ov10
oviI
OV12
OV13
OV14
OV15
OV16cOndty aumysis on biera ovaran bunours
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Statistical analysis of the LOH data was performed accord-
ing to Jacobs et al. (1992) with minor modifications. Where n
deposits of a tumour have loss of heterozygosity for a
polymorphism, the probability of each deposit losing the
same allele as an independent even is (1 2)" . This approach
does not take the locus-specific chance for allele loss into
consideration. In order to do this. chromosome arm-specific
LOH frequencies were derived from the pooled data of four
ovarian cancer allelotype studies (Sato et al., 1991; Cliby et
al.. 1993; Yang-Feng et al., 1993; Osborne and Leech, 1994).
For a locus i the LOH frequency is x,. If LOH of locus i is
observed for tumour a, the probability that LOH occurred at
this locus in tumour b independently is xi, and the pro-
bability that the same allele is involved is xV. The probability
that in a specific case all observed concordant LOH patterns
occurred as independent events is equal to the product of the
single probabilities and is designated as the probability of
independent origin (PIO). In the calculation of the PIOs we
used a conservative approach. For example, when multiple
markers on the same chromosomes showed LOH (indicating
loss of a whole chromosome) only the highest LOH fre-
quency was included in the PIO calculation since these multi-
ple LOH patterns were probably not independent events.
The same was done for cases where identical chromosomal
breakpoints were found. It should be considered however,
that the probability that chromosomal breakpoints independ-
ently occur in the same region in two tumour deposits will
probably be lower than the regional LOH frequency.
Table I11 Companrson of DNA flow cvtometry and LOH-denved
probabilities ofindependent ongin
Probability of
Group Case DI. DIb LR independent origin
I OV13 1.9 1.0 1.29 x 10-- ° 0.000021
OV2 2.0 2.0 5.85 0.00052
OV16 0.9 0.9 5.85 0.00097
OV12 1.8 1.7 1.39 0.0053
OV15 1.3 1.3 5.85 0.0043
OVi 1.6 1.6 5.85 0.050
OV4 1.2 1.2 5.85 0.043
OV6 2.0 2.0 5.85 0.026
OV14 1.7 1.6 1.39 0.060
OV5 1.7 1.9 18 x 10-1 0.28
OV7 1.8 1.8 5.85 -
OV8 1.5 1.4 1.39 -
II OVI l 1.6 1.7 1.39 0.0089
OV9 1.4 1.3 1.39 0.28
III OV3 1.3 1.3 5.85 -
OVIO 1.5 1.9 5.77 x 10-10 -
cn
a)
lo.
0
.0
E
z
Results
Flow cvtometrv
Nuclear suspensions of all samples were prepared for DNA
ploidy analysis. In eight of the 16 cases (OVI, OV2, OV3,
OV4. OV6. OV7. OV15 and OV16) the DI was identical in
both tumour sites investigated, in five cases (OV8, OV9.
OVI1. OV12 and OV14) the difference in DI was relatively
small (0.1) and in three cases DIs between 0.2 and 0.9 were
observed (OV5. OV10 and OV13) (Table III). In Figure 1 the
DNA histograms of tumour a and tumour b from case OV14
are shown. Both histograms show an aneuploid population
with almost similar DIs (1.7 and 1.6) with varying fractions
of diploid cells. The LR of 1.39 calculated for this case is
slightly in favour of a unifocal origin. In a total of 14 cases
DIs were compatible with a unifocal origin (LR range
1.39-5.85). The extremely low LRs found for cases OV5,
OVIO and OV13 made it unlikely that the differences in DI
were caused by measurement errors, and thus indicate true
biological differences.
Detection ofLOH
Samples from 24 out of 32 tumours were enriched for their
tumour cell content by flow cytometric cell sorting based on
DNA aneuploidy (Table I). The effect of the enrichment is
demonstrated in Figure 2. Both sorted diploid fractions of
OV11 show two constitutional alleles for microsatellite
marker D18S34, while a relative intensity decrease of the
upper allele in the unsorted samples was observed, strongly
suggesting LOH which is confirmed by PCR amplification of
the aneuploid fraction showing a complete loss of the upper
allele. The results of comparative LOH analysis of the 16
tumour pairs are summarised in Figure 3. Fourteen cases
were informative concerning LOH. The cases were divided
into three groups according to concordant or discordant
LOH patterns. Group I includes 12 cases showing concor-
dant LOH and ROH patterns for all informative markers.
Within this group cases are ranked according to the number
of loci showing concordant LOH, ranging from six (case
OV13) to zero concordant LOH patterns. Case OV7 was also
included in this group although no LOH was detected at any
of the investigated loci. For case OV8 no signal was obtained
for chromosome 22 in tumour b but concordance was
c;
C-,
0
o
.0
E
z
OV14a
an
0 200
OV14b
0 200 400 600 800 1000
DNA content
Fgure 1 DNA histograms from two ovarian tumours. located in
the left (OV14a) and the right (OV14b) ovary. In both histograms
three peaks are visible: trout erythrocytes (tr) used as a ploidy
reference. the G1.0 from the DNA diploid population (di) and the
G10 from the DNA aneuploid population (an).
observed for all other markers. The calculated probabilities
that the observed LOH patterns could have occurred by
coincidental loss of the same allele at all loci ranged from
0.000021 to 0.28 (Table III). Because of the absence of
concordant LOH patterns no probabilities could be cal-
culated for cases OV7 and OV8. The LOH data and the
calculated probabilities are in most cases highly suggestive
for a unifocal origin of the tumours.
Cases in group III show discordance for all observed LOH
patterns. Loss of opposite alleles was not observed.
1
1332OViI1: Dl18S34
a a a b b b
di an T di an T
Figwe 2 LOH analysis on DNA isolated from tumour fractions
enriched by flow cytometry on the basis of DNA ploidy
differences. Sorted fractions (di = diploid and an = aneuploid)
from both tumours (a and b) were compared with unsorted
tumour cell samples (T). Nuclei from case OVII were isolated.
LOH analysis was performed with microsatellite markers:
D18S34.
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Remarkably, in both cases LOH was found in only one
tumour site (OV3b and OV1Ob).
Group II consists of two cases which showed concordant
as well as disconcordant LOH patterns. Figure 4 shows the
partial alielotype for four informative microsatellite markers
of case OVI1. LOH can be observed in the aneuploid frac-
tion of tumour a as well as in the aneuploid fraction of
tumour b for D17S588 since in both lanes the upper allele is
completely lost, while ROH was observed for marker
D3S1270. However, only the aneuploid fraction of tumour a
shows LOH for the chromosome 6 markers F13AI and
D6S251 while ROH for tumour b was observed. The markers
for the other chromosomes all showed concordant patterns
(LOH for chromosomes 17, 18p and 22 and ROH for
chromosomes 3, 11, 18q and X). Together with identical
chromosome 18 breakpoints in both tumours (between
D18S34 and D18S40) this strongly suggests a unifocal origin.
This is supported by the calculated PIO of 0.0089. Although
in case OV9 an independent origin cannot be excluded on the
basis of a PIO of 0.28, the presence of identical chromosome
Group Chromosome
Cas
1
ab
3
ab
6
ab
11 17 18 22
ab ab ab ab
x
ab
11
Fugwe 3 Graphic representation of the allelotypes of the ovarian tumours for chromosomes 1, 3, 6, 11, 17, 18, 22 and X. The left
chromosome of each chromosome pair corresponds to tumour a and the right chromosome to tumour b of each case. The small
numbers indicate the number of informative markers for each chromosome. Black symbols indicate LOH, white symbols ROH.
When microsatellite markers could not properly be amplified or where all tested markers were homozygous for a specific
chromosome no chromosome symbol was drawn. Case numbers are indicated at the left side. The cases are grouped according to
the occurrence ofconcordant LOH patterns. Within the groups the cases were ranked according to descending number of observed
LOH events.aad II- - 1i bms
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case: OViI1
D3S1270
a a b b
di an di an
D6S251
a a b b
di an ci an
F13A1
a a b b
di an di an
D17S588
a a b b
di an di an
Fugwe 4 Partial alelotype of case OVl1. Four different DNA samples were amplified with microsatellite markers D3S1270,
D6S251, F13A1 and D17S588. LOH can be observed in the aneuploid fractions of tumour a and tumour b with marker D17S588
and retention with marker D3S1270. For the microsatellite markers located on chromosome 6 (D6S251 and F13AI) only tumour a
has lost an allele while tumour b shows retention of heterozygosity.
17 breakpoints, identified by four informative markers is still
strongly suggestive of a unifocal origin of both tumours.
LOH vs DNA index
In group I identical allelotypes correlate to equal or nearly
equal DIs (d= <0.1) in all cases except OV5 and OV13.
However, the PIO values show a much higher variation than
the LRs for these cases. Although, for OV13 the LOH
patterns are totally identical for all informative markers on
seven different chromosomes (PIO = 0.000021), a large
difference in DI was observed (LR = 1.29 x 10-'). This dis-
crepancy can be explained by assuming that the aneuploid
stemline in tumour a represents a tetraploidised subclone of
the diploid sline of tumour b. This subclone must have
orginated after the establishment of the observed allelotype.
In case OV5 neither DNA ploidy analysis nor the
allelotype can exclude an independent origin. Although both
tumours lost the complete chromosome 17 this still could be
an independent event since loss of chromosome 17 is very
common in ovarian tumours. Despite a non-complete iden-
tity of the allelotypes of the two cases in group H the FCM
results are also in favour of a unifocal origin of the tumours.
In group m the discordant LOH patterns correlate with
differences in DNA index for case OV1O while the two
methods gave contradictory results for OV3.
In the present study two different genetic approaches were
used to study the origin of bilateral ovarian tumours. We
found evidence for a unifocal origin in 14 of 16 cases on the
basis of LOH analysis, whereas DNA ploidy analysis did not
always provide conclusive evidence about the origin of
tumours. The use of DNA ploidy analysis is based on the
assumption that identical, aneuploid DIs are not likely to be
the product of an independent ploidy evolution but rather
reflect a unifocal origin. DNA FCM is a rapid technique
which is used in many clinical pathological laboratories
throughout the world. A limitation to this type of analysis is
that ploidy evolution may continue after the formation of
metastases, e.g. by tetraploidisation. This would result in a
DI difference that might be interpreted as evidence against a
unifocal origin. An illustration of this phenomenon is case
OV13 in which DIs of 1.9 and 1.0 were observed while the
allelotype was completely identical including LOH at six
different chromosomes (Figure 3). Tetraploidisation appar-
ently occurred after establishment of the allelotype. Also in
the case of DI heterogeneity in the primary tumour meta-
stasis of a minor subpopulation not detected in the primary
tumour might yield a similar DI difference. Apart from this
the limited resolution of DNA FCM which on average can-
not detect DNA content differences less than 5% may lead to
spurious identity of DIs.
Microsatellite-based LOH analysis can detect genetic
differences at the subchromosomal level and is intrinsically
more sensitive and specific. In contrast to DNA ploidy
analysis, ongoing clonal evolution at different tumour loca-
tions might not preclude the identification of a unifocal
origin owing to the clonal retention ofacquired genetic aber-
rations, e.g. the two cases OV9 and OVll in group II. The
specifiity of this approach depends on the number of
independent LOH events as well on the a priori probability
that a certain chromosome region will show LOH, e.g.
regions harbouring tumour-suppressor genes. For instance, a
coincidental, identical LOH pattern for chromosome 17 will
be more likely than for chromosome 1. We have corrected
for this in our calculations. With the present availability of
highly polymorphic micro-satellite markers, the accurate
mapping of chromosomal breakpoints can substantially in-
crease the power of this type of analysis and provide definite
answers about the clonality of multiple tumours. Identical
chromosomal breakpoints are a strong indication of a
unifocal origin. The accuracy by which the exact position of
breakpoints and thus their identity can be determined,
depends on the proximity of the flanking microsatellite
markers. Other PCR-based methods that can provide inform-
ation about the origin ofmultiple tumours are determination
of X-chromosome inactivation (Allen et al., 1992), oncogene
amplification (Li et al., 1994) and determination of oncogene
or tumour-suppressor gene mutations. The use of X
chromosome inactivation is hampered by the fact that half of
the multifocal tumours will have identical inactivation just by
chance. Oncogene amplification is less informative because
(1) a limited number ofchromosomal regions is known to be
involved and (2) certain amplicons are strongly correlated
with certain tumour types which makes an independent
amplification in both tumours rather likely and therefore less
appropriate. Mutation analysis of frequently involved
oncogenes or tumour-suppressor genes like p53 is highly
informative and applicable in many kinds of tumours includ-
ing ovarian tumours. Disadvantages are the lack of muta-
tions in a high percentage of tumours (for ovarian tumoursClonaly analysis on bla wrarian tumours
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about 50%), presence of mutational hot spots (ras, p53) and
the possibility that a mutation occurs after metastatic spread.
A limitation of LOH analysis on DNA extracted from
total tumour tissue is the fraction contaminating non-
neoplastic cells. Under optimal conditions the minimum
amount of tumour cells should exceed 40% (Gruis et al..
1993). We recently showed that tumour specimens with lower
amounts of neoplastic cells can be made accessible for PCR-
based LOH analysis by flow sorting of tumour cells on the
basis of DNA ploidy and marker expression (Abeln et al..
1994). In the present study this enabled us to successfully
enrich 24 of the 32 tumours where otherwise 18 tumours
would have been excluded owing to low tumour cellulan'ty.
In 10 of the 16 investigated cases statistical evidence of
unifocal origin was found on the basis of LOH and in two
cases (OV5 and OV9) evidence was obtained which suggested
unifocal origin but failed to reach the level of statistical
significance. For case OV9 the identical chromosome 17
breakpoint in both tumours provides strong evidence for a
common origin of the different tumour sites. These findings
are in agreement with previous reports based on DNA flow
cytometry, karyotyping, p53 mutation analysis or allelotyp-
ing (Smit et al., 1990; Pejovic et al., 1991; Jacobs et al., 1992;
Mok et al., 1992) in which 31 43, 11 11, 9 9 and 15 17
respectively. showed evidence for unifocal origin.
From a theoretical point of view formal proof that
tumours are multifocal is quite difficult. Only if the initial
molecular event is known (as in e.g. APC mutation in col-
orectal adenoma development; Powell et al.. 1992) discor-
dance for this marker will be direct proof of multifocality.
The tumours in group III showed discordant LOH which
suggests but does not prove multifocality since post-
metastatic LOH does occur as evidenced by the tumours in
group LI.
The PIO calculation is correct under the condition that
LOH is non-parental origin-specific. If a certain
chromosomal region harbouring a tumour-suppressor gene is
imprinted, loss of the other allele may totally switch off its
suppressor function and will provide selective advantage with
regard to carcinogenesis. The chance that two tumours in a
patient independently lose the non-imprinted allele therefore
may be higher than in a non-imprinted situation. In this case
the PIO would be a less accurate measure for independent
origin. The same holds for cases where LOH is the second hit
uncovering a germline mutation according to Knudson's two-
hit tumour-suppressor gene model, but this will be restricted
to familial tumours. Parental specific LOH has been reported
for some cases (reviewed by Feinberg, 1993) concerning
Wilms' tumour, rhabdomyosarcoma, bilateral retinoblas-
toma, unilateral retinoblastoma. acute myelogenous
leukaemia and neuroblastoma concerning regions on
chromosomes 1, 2, 7, 11 and 13. However this phenomenon
has not been reported for ovarian cancer, although LOH at
chromosome 11 is a frequent event. However both for the
imprinted as well as in familial tumours. partial LOH
generating a chromosomal breakpoint. would still enable
discrimination of multifocal from unifocal onrgin.
In our series chromosomes 6. 11. 17 and 18 were most
frequently involved in LOH. LOH at 6q was previously
reported to be a common event (51%) in ovarian tumours
(Saito et al.. 1992). although a candidate tumour-suppressor
gene has not yet been reported in this region. WTI may be a
target gene for the loss of chromosome 11 (Eccles et al..
1992: Foulkes et al.. 1993). TP53 could be the target gene for
the chromosome 17p loss, since the gene is frequently
involved in ovarian cancer (Milner et al., 1993). For BRCAJ
which also maps to chromosome 17. recently both germline
(Futreal et al., 1994) as well as somatic mutations have been
found in ovarian cancer (Hosking et al.. 1995: Merajver et
al.. 1995) although a second gene on 17q may be a more
likely target (Saito et al.. 1993). Frequent LOH at 18q (60%)
has also previously been reported. however the smallest
region of overlap seems to exclude the DCC tumour-
suppressor gene (Chenevix-Trench et al.. 1992).
Interestingly two cases, OV9 and OVI 1. showed discordant
LOH patterns for chromosomes 6 and 18 and concordance
was observed at other loci. In contrast. relatively high LOH
frequencies for chromosomes 6 (62%) and 18 (43%) were
reported by Cliby et al. (1993). Our results suggest that LOH
at chromosomes 6 and 18 may represent late events in
tumour progression which in some tumours may not be
essential for establishing the malignant phenotype. Whether
the absence of LOH at chromosomes 6 and 18 respectively.
in one of the sites definitely identifies these as the primary
tumours is still unclear. Evidence for clonal divergence was
previously reported by Jacobs et at. (1992) although in this
study fewer loci were investigated.
Our results support the evidence for a monoclonal origin
of the majority of bilateral ovarian carcinomas. PCR-based
LOH analysis proved to be a more reliable technique for
clonality determination than DNA FCM. The results
obtained with both techniques indicate that clonal divergence
after metastasis is an infrequent phenomenon in ovarian
cancer.
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